Bay Street News, January 4th, 2019

Biogen made a one-time upfront $74 million payment to Skyhawk for research services and an exclusive license to therapeutic candidates […]

Summit Therapeutics plc(“Summit Therapeutics” or the “Company”) Result of General Meeting Oxford, UK, and Cambridge, MA, US, 4 January 2019 […]

JOHNS CREEK, Ga., Jan. 04, 2019 (GLOBE NEWSWIRE) — Saia, Inc. (NASDAQ: SAIA), a leading transportation provider offering multi-regional less-than-truckload […]

EXTON, Pa., Jan. 04, 2019 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today announced that the company will present […]

Acquisition strengthens U.S. platform in important Mid-Atlantic Region TORONTO and NORFOLK, Va., Jan. 04, 2019 (GLOBE NEWSWIRE) — Leading global […]

TORONTO and OTTAWA, Ontario, Jan. 04, 2019 (GLOBE NEWSWIRE) — Internet of Things Inc. (TSX VENTURE: ITT; OTC: INOTF; FRANKFURT: […]

GOLETA, Calif., Jan. 04, 2019 (GLOBE NEWSWIRE) — Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, […]

GAITHERSBURG, Md., Jan. 04, 2019 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today announced that its CEO Daniel J. […]

RESEARCH TRIANGLE PARK, N.C., Jan. 04, 2019 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company has […]

–     Esperion to Receive $300 Million in Upfront and Near-term Milestones    ––     Up to $900 Million in Total […]